Microbot Medical wins Surgical Robotics Industry Innovative Start-Up Award for LIBERTY System

Microbot Medical Inc.

Won the Innovative Start-Up Award from Surgical Robotics Technology (SRT) for the LIBERTY Endovascular Robotic System.
LIBERTY is the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
Reports continued adoption since Full Market Release in April; now used at leading academic centers across NY, PA, FL, GA, MA, MI, NC.
CEO Harel Gadot stated the award validates LIBERTY's mission to redefine endovascular intervention and expand access.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.